Lars Werntz

Publication Activity (10 Years)

Years Active: 2018-2018
Publications (10 Years): 1

Top Topics

Atrial Fibrillation

Pulmonary Arterial Hypertension

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Huppertz, Lars Werntz, Andreas Daniel Meid, Kathrin I Foerster, Juergen Burhenne, David Czock, Gerd Mikus, Walter Emil Haefeli
Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided. British journal of clinical pharmacology 84 (12) (2018)